Mode Switching Is the Major Mechanism of Ligand Regulation of InsP(3) Receptor Calcium Release Channels

por Ionescu, Lucian, White, Carl, Cheung, King-Ho, Shuai, Jianwei, Parker, Ian, Pearson, John E., Foskett, J. Kevin, Mak, Don-On Daniel
Publicado 2007

Certolizumab Pegol Efficacy Across Methotrexate Regimens: A Pre‐Specified Analysis of Two Phase III Trials

por Combe, Bernard, Furst, Daniel E., Keystone, Edward C., van der Heijde, Désirée, Luijtens, Kristel, Ionescu, Lucian, Goel, Niti, Emery, Paul
Publicado 2016

Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study

por Glatt, Sophie, Taylor, Peter C, McInnes, Iain B, Schett, Georg, Landewé, Robert, Baeten, Dominique, Ionescu, Lucian, Strimenopoulou, Foteini, Watling, Mark I L, Shaw, Stevan
Publicado 2019

Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial

por Glatt, Sophie, Jemec, Gregor B. E., Forman, Seth, Sayed, Christopher, Schmieder, George, Weisman, Jamie, Rolleri, Robert, Seegobin, Seth, Baeten, Dominique, Ionescu, Lucian, Zouboulis, Christos C., Shaw, Stevan
Publicado 2021

Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F co...

por Glatt, Sophie, Baeten, Dominique, Baker, Terry, Griffiths, Meryn, Ionescu, Lucian, Lawson, Alastair D G, Maroof, Ash, Oliver, Ruth, Popa, Serghei, Strimenopoulou, Foteini, Vajjah, Pavan, Watling, Mark I L, Yeremenko, Nataliya, Miossec, Pierre, Shaw, Stevan
Publicado 2018